These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16970095)

  • 1. [Protective effects of triptolide on the lipopolysaccharide-mediated degeneration of dopaminergic neurons in substantia nigra].
    Li G; Ma R; Xu Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Aug; 26(8):715-8. PubMed ID: 16970095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
    Gao JP; Sun S; Li WW; Chen YP; Cai DF
    Neurosci Bull; 2008 Jun; 24(3):133-42. PubMed ID: 18500385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection.
    Zhou HF; Liu XY; Niu DB; Li FQ; He QH; Wang XM
    Neurobiol Dis; 2005 Apr; 18(3):441-9. PubMed ID: 15755670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra.
    Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation.
    Li FQ; Lu XZ; Liang XB; Zhou HF; Xue B; Liu XY; Niu DB; Han JS; Wang XM
    J Neuroimmunol; 2004 Mar; 148(1-2):24-31. PubMed ID: 14975583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress.
    Chung ES; Chung YC; Bok E; Baik HH; Park ES; Park JY; Yoon SH; Jin BK
    Brain Res; 2010 Dec; 1363():143-50. PubMed ID: 20858471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
    Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats.
    Li G; Sun S; Cao X; Zhong J; Tong E
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):83-6. PubMed ID: 15165124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
    Sharma N; Sharma S; Nehru B
    Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease].
    Wang PQ; Sun SG; Qiao X
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1346-50. PubMed ID: 19615192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE; Cicchetti F; Hennen J; Isacson O
    Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of inducible nitric oxide synthase in lipopolysaccharide-mediated degeneration of dopaminergic neurons].
    Li G; Ma R; Sun SG; Tong ET; Yuan GL
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3177-81. PubMed ID: 17313781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
    Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
    Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of tripchlorolide on dopaminergic neurons in partially lesioned rat model of Parkinson's disease].
    Cheng XX; Li FQ; Huang M; Wang XM; Han JS
    Yao Xue Xue Bao; 2002 May; 37(5):339-42. PubMed ID: 12579836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cinnabar and realgar of WSHFD in protecting against LPS-induced neurotoxicity.
    Zhang F; Lu Y; Wu Q; Yan J; Shi J; Liu J
    J Ethnopharmacol; 2012 Feb; 139(3):822-8. PubMed ID: 22207210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.
    Liu B; Jiang JW; Wilson BC; Du L; Yang SN; Wang JY; Wu GC; Cao XD; Hong JS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):125-32. PubMed ID: 10991969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats.
    Ji A; Diao H; Wang X; Yang R; Zhang J; Luo W; Cao R; Cao Z; Wang F; Cai T
    Neurotoxicology; 2012 Aug; 33(4):780-8. PubMed ID: 22406923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.